Wound Infection Detection via Bacterial Protease Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing chronic wound infections are inadequate, relying on clinical signs that can be non-specific and delayed, especially in patients with co-morbidities, leading to potential amputation or systemic infections due to the inability to accurately detect bacterial pathogenesis and protease activity.
Innovation Solution
A method involving contacting a wound test sample with a human neutrophil elastase inhibitor and a bacterial protease substrate, such as casein labeled with fluorescein isothiocyanate, to detect bacterial protease activity, which indicates local bacterial infection, critical colonization, or bacterial infection, allowing for early intervention.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If clinical signs and symptoms (NERDS) are used to diagnose wound infection, then the diagnosis can be made using simple observation, but the detection is delayed and non-specific, leading to missed early infection signs
Solution Approach 1:
The patent introduces bacterial protease activity as an intermediary marker that bridges the gap between simple observation and accurate infection detection. By measuring protease activity in wound exudate, the test provides an objective quantifiable indicator that reflects bacterial pathogenesis before clinical signs become apparent, resolving the contradiction between diagnostic simplicity and detection accuracy
Solution Approach 2:
The invention enables preliminary detection of bacterial pathogenesis by measuring protease activity before clinical infection signs develop. This preliminary action allows early intervention by identifying wounds at risk of infection based on bacterial protease presence, rather than waiting for non-specific clinical signs to manifest
2Measurement precision
If bacterial protease activity measurement is implemented, then early and accurate detection of bacterial pathogenesis is achieved, but the diagnostic process becomes more complex requiring specialized reagents and equipment
Solution Approach 1:
The patent transforms the diagnostic approach by changing the measured parameter from subjective clinical signs to objective bacterial protease activity levels. This parameter change enables precise quantification of infection risk using enzymatic activity assays, which can be performed with standard laboratory equipment, balancing improved detection accuracy with manageable system complexity
Solution Approach 2:
The invention replaces the mechanical/visual assessment system (clinical observation of NERDS signs) with a biochemical detection system measuring protease enzymatic activity. This substitution provides more accurate and objective results by detecting molecular-level bacterial pathogenesis mechanisms rather than relying on visible clinical manifestations
3Ease of manufacture
If clinical signs are waited for before intervention, then treatment can be conservative and targeted, but the window for effective intervention is lost, leading to severe outcomes like amputation
Solution Approach 1:
The patent enables preliminary identification of wounds with bacterial protease activity before clinical infection signs develop. This preliminary detection creates an early intervention window where conservative treatments can be applied to prevent progression to severe infection, avoiding the need for aggressive interventions like amputation while still providing timely treatment
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the detection of bacterial pathogenesis and non-healing wounds by measuring bacterial protease activity, providing an objective assessment that can precede visible clinical signs and bioburden thresholds, facilitating timely treatment and improving patient outcomes.
Implementation Method 1
contacting a test sample from a wound with a human neutrophil elastase inhibitor and a bacterial protease substrate; and detecting the amount of bacterial protease activity on the substrate
Implementation Method 2
The casein can be labeled with fluorescein iso-thiocyanate
Data Source
AI summary
Methods of detecting a local infection, critical colonization, or infection in a wound, predicting wound healing in a wound, and detecting bacterial pathogenesis in a wound are provided.